Home | Welcome to Contract Pharma   
Last Updated Saturday, May 18 2013
Print

Topics - R&D


Refine by Date:
From: To:
Pipe(line) Dreams?
By Thaddeus Wolfram, PA Consulting Group
Published January 22, 2013
Making the most of your R&D portfolio potential Read More »
The Data Difference
By Geri Studebaker, Aegis Analytical Corp.
Published November 9, 2012
How CMOs can use data to innovate for better sponsor collaboration Read More »
Newsmakers: Phil Hodges
By Gil Y. Roth, Contract Pharma
Published November 9, 2012
Phil Hodges on Selling Metrics Read More »
ADCs and Outsourcing
By Tom Spurgeon, Contract Pharma
Published September 6, 2012
Fortune and opportunity in a burgeoning class of therapies Read More »
Newsmakers: Scott Houlton
By Gil Y. Roth, Contract Pharma
Published September 6, 2012
Catching up with the president of Development & Clinical Services Read More »
Resizing the Global Contract R&D Services Market
By Kenneth Getz, Mary Jo Lamberti, Adam Mathias, Stella Stergiopoulos, Tufts CSDD
Published May 30, 2012
A new study revises estimates of the market Read More »
CRO Outlook & Opportunities
By Kristin Brooks, Contract Pharma
Published May 30, 2012
e-Clinical solutions fuel advances Read More »
Drug Delivery Collaborations
By Craig Thomson, Murgitroyd & Company
Published May 30, 2012
Ensuring collaborations enhance rather than stifle development of new technology Read More »
Newsmakers: Clive Bennett
By Gil Y. Roth, Contract Pharma
Published May 30, 2012
Halo CEO Clive Bennett Read More »
Building Flexibility
By Kuljit S. Bhatia, DPT Laboratories
Published May 30, 2012
A new business model for a volatile industry Read More »
Evolving Tactical Relationships Into Global Partnerships
By Andrew Townshend and Ian Lauf, MBA, INC Research and Boehringer-Ingelheim
Published May 30, 2012
Sponsor-CRO relationships in transition Read More »
Clinical Trial Operations
By Roger Parlett, Almac
Published May 30, 2012
Packaging design can affect material need and IVR complexity Read More »
By Gil Roth, Contract Pharma
Published May 4, 2012
FDA’s draft guidance leads to new opportunities Read More »
Expression Technologies
By Joel White, Ajinomoto North America
Published May 4, 2012
To Outsource or License? Read More »
Newsmakers: Jim Mullen
By Gil Y. Roth, Contract Pharma
Published May 4, 2012
Patheon's CEO talks about his first year on the job Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On